Rockefeller Capital Management L.P. Bellerophon Therapeutics, Inc. Transaction History

Rockefeller Capital Management L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.36 - $4.05 $12,980 - $22,275	-5,500 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.75 - $4.86 $3,750 - $4,860	1,000 Added 22.22%	5,500 $22,000
Q2 2021 Aug 10, 2021	BUY	$3.83 - $5.65 $17,235 - $25,425	4,500 New	4,500 $21,000

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $477K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.